ОБ ЭТОМ ЭПИЗОДЕ
Today we're joined by Mike Horowitz and Scott Patterson, co-founders of Modulo.
Modulo is designing therapeutics to reprogram your neuroimmune system by focusing on microglia cells—the swiss army knife of the brain.
In this episode we get into the potential of microglia and why it has taken so long to uncover it, the impetus behind starting Modulo, and how we can combat neurodegenerative diseases from frontotemporal dementia to Alzheimer's and beyond. You can learn more about Modulo here
Show notes:
book mentioned: Angel and the Assasin
Wired article
Community advocate for C9orf72
Lee Holloway story
английский
США
РАСШИФРОВКА 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
ПОИСК ПРОШЛЫХ ЭПИЗОДОВ
Искать прошлые эпизоды Near Frontier.
ДРУГИЕ ЭПИЗОДЫ В ЭТОМ ПОДКАсте
Today we're joined by Tessa Lau, founder and CEO of Dusty Robotics, a Bay Area construction robotics company. We talk to Tessa about the vision for Dusty, how she got started, dealing with supply chain, selling into construction, and her advice for new deep tech founders. If you're interested in ro…
We talk to Prellis Biologics founder Melanie Matheu about bioprinting organs with Prellis' holographic laser technology, using bioprinted lymph node organoids for antibody discovery, and Melanie's advice for new bio founders with regards to choosing focus and setting early partnerships.
Note: We …
Cantos analysts Amee and Andrew dive into their top predictions for what deep tech might see in 2022.
Shownotes:
Our 2022 predictions blog post
Trailblazer's List by Mina Fahmi: https://trailblazerlist.xyz/
Loonshots by Safi Bahcall
Speed & Scale by John Doerr
New funding models in bio…
Today we're joined by Anna Perdrix Rossell and George Foot of Sixfold Bioscience, co-founders of Sixfold Bioscience, a UK based biotech company using computation and advanced chemistry to engineer highly programmable constructs that make the delivery of RNA therapeutics predictable and precise. Six…
Today we're joined by Dr. Joshua Britton, founder and CEO of Debut Biotech, a cell-free biomanufacturing company. Josh gives us a crash course on synthetic biology and biomanufacturing, walking us through the various methods and promise of this industry that may very well shift industrial productio…
Отказ от ответственности: Подкаст и иллюстрации, встроенные в эту страницу, взяты из Cantos Ventures, который является собственностью его владельца и не связан или не одобрен Listen Notes, Inc.
ИЗМЕНИТЬ
Спасибо, что помогаете поддерживать базу подкастов актуальной.
